This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (33)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

DONALD BERKOWITZ, M.D.; DAVID SKLAROFF, M.D.

AMA Arch Intern Med. 1957;100(6):951-958.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Until recently, methods to detect abnormalities in fat absorption have been based on procedures that are difficult to obtain and technically difficult to perform in the average hospital, i. e. fecal fat studies, chylomicron counts, vitamin A tolerance tests, and plasma lipid determinations. A measure of pancreatic enzymes by intubation techniques is likewise not generally available.

The accessability of I¹³¹-labeled triolein now makes it possible to study fat absorption much more readily. Since Thannhauser and Stanley first reported their results, in 1949,¹ a large experience has accumulated which attests to the simplicity and reliability of the method.

We have attempted to evaluate the radioactive fat (RAF) test in a large general hospital, where, because of laboratory limitations, the assessment of fat malabsorption has always been difficult. The present study reviews our findings with 200 such tests.

Procedure

In general, we have followed the procedure outlined by Ruffin. . . . [Full Text PDF of this Article]

Author Affiliations
Philadelphia

From the Departments of Medicine and Radiology, Albert Einstein Medical Center, Northern Division.

Footnotes
Submitted for publication June 24, 1957.

Read before the Section on Internal Medicine at the 106th Annual Meeting of the American Medical Association, New York, June 5, 1957.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?